A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Rodriguez, Christophe ^a,b   Soulier, Alexandre ^a,b   Demontant, Vanessa ^a,b   Poiteau, Lila ^a,b   Mercier Darty, Mélanie ^a,b   Bouvier Alias, Magali ^a,b   Pawlotsky, Jean Michel ^a,b   Chevaliez, Stéphane ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM U955   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; HEPATITIS C VIRUS GENOTYPE 2; HUMAN; HUMAN TISSUE; NONHUMAN; SANGER SEQUENCING; CHRONIC HEPATITIS C; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HEPACIVIRUS; HIGH THROUGHPUT SEQUENCING; PHYLOGENY; PROCEDURES;

GENOTYPE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PHYLOGENY;

EID: 85048298181     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-22614-0     Document Type: Article

References (27)

1. Polaris Observatory, H. C. V. C. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2, 161-176, https://doi.org/10.1016/S2468-1253(16)30181-9 (2017).
2. Smith, D. B. et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59, 318-327, https://doi.org/10.1002/hep.26744 (2014).
3. Hedskog, C. et al. Identification of novel HCV genotype and subtypes in patients treated with sofosbuvir based regimens. Hepatology 66, 121A (2017).
4. Simmonds, P. Variability of hepatitis C virus. Hepatology 21, 570-583 (1995).
5. Belperio, P. S., Chartier, M., Ross, D. B., Alaigh, P. & Shulkin, D. Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs. Ann Intern Med 167, 499-504, https://doi.org/10.7326/M17-1073 (2017).
6. Falade-Nwulia, O. et al. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. Ann Intern Med 166, 637-648, https://doi.org/10.7326/M16-2575 (2017).
7. European Association for the Study of the Liver. Electronic address, e. e. e. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol 66, 153-194, https://doi.org/10.1016/j.jhep.2016.09.001 (2017).
8. Panel, A. I. H. G. H. C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 62, 932-954, https://doi.org/10.1002/hep.27950 (2015).
9. Chevaliez, S., Bouvier-Alias, M., Brillet, R. & Pawlotsky, J. M. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 4, e8209, https://doi.org/10.1371/journal.pone.0008209 (2009).
10. Mallory, M. A. et al. Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing. J Clin Virol 90, 26-31, https://doi.org/10.1016/j.jcv.2017.03.007 (2017).
11. Nieto-Aponte, L. et al. Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing. J Clin Microbiol 55, 504-509, https://doi.org/10.1128/JCM.01960-16 (2017).
12. Quer, J. et al. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J Clin Microbiol 53, 219-226, https://doi.org/10.1128/JCM.02093-14 (2015).
13. Del Campo, J. A. et al. HCV deep-sequencing for sub-genotypes identification of mixed infections: a real life experience. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2017.12.016 (2017).
14. Rodriguez-Frias, F. et al. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping. Clin Microbiol Infect 23, 775 e771-775 e776, https://doi.org/10.1016/j.cmi.2017.02.007 (2017).
15. Chevaliez, S., Bouvier-Alias, M. & Pawlotsky, J. M. Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification. J Clin Microbiol 47, 1726-1732, https://doi.org/10.1128/JCM.01300-08 (2009).
16. Sandres-Saune, K. et al. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109, 187-193 (2003).
17. Simmonds, P. et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 75(Pt 5), 1053-1061, https://doi.org/10.1099/0022-1317-75-5-1053 (1994).
18. Morice, Y. et al. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 82, 1001-1012, https://doi.org/10.1099/0022-1317-82-5-1001 (2001).
19. Bronowicki, J. P. et al. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology 131, 1040-1048, https://doi.org/10.1053/j.gastro.2006.07.022 (2006).
20. Felsenstein, J. PHYLIP: phylogeny inference package, version 3.5c (computer program). Distributed by the author. Department of Genetics, University of Washington, Seattle (1993).
21. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680 (1994).
22. Salemi, M. & Vandamme, A. M. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J Mol Evol 54, 62-70 (2002).
23. Pybus, O. G. & Rambaut, A. Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 10, 540-550, https://doi.org/10.1038/nrg2583 (2009).
24. Kalinina, O., Norder, H., Mukomolov, S. & Magnius, L. O. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76, 4034-4043 (2002).
25. Guelfo, J. R. et al. Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment. J Clin Microbiol 52, 4027-4029, https://doi.org/10.1128/JCM.02209-14 (2014).
26. Dirani, G. et al. A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping. J Virol Methods 251, 88-91, https://doi.org/10.1016/j.jviromet.2017.10.005 (2017).
27. Welzel, T. M. et al. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. J Hepatol 67, 224-236, https://doi.org/10.1016/j.jhep.2017.03.014 (2017).